Cryotomy in a Mohs service: the Welsh experience

Pioneered in the 1930s in the USA by Dr Frederic Mohs (1910–2002), Mohs micrographic surgery is a highly effective means of treating certain types of primary skin cancer, most commonly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). These occur most frequently on the head and neck, with clinically invisible microscopic extensions, or situated on critical anatomical structures such as the nose, eyelid, lip or ear. It is vital to remove all the tumour to prevent recurrence, yet also desirable to minimise loss of normal skin tissue to avoid cosmetically unsightly wounds. The Thermo Scientific Cryostar cryostat can help to optimise workflow and throughput in the modern Mohs clinic, enabling more patients to be seen per clinic session.

This story is Premium Content and is only available to registered users. If you don't already have an account, please register with us completely free of charge.
 

Other news

Upcoming Events

Update Course in Gynaecological Cytology

London Regional Cytology Training Centre, Level 6X, St Marks Building, Watford Road, Harrow HA1 3UJ
12-14 December 2018

Managing Cultural Differences in the Workplace

The Holiday Inn - Kensington Forum, 97 Cromwell Road, London SW7 4DN
21 January 2019

British Society for Haematology Paediatric Symposium

Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London WC1X 8SH
14 February 2019

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Dec 2018

Molecular diagnostics and LAMP technology

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.